Dr. Amit Kumar is Consultant, Paediatric Oncology at HCG
He pursued Fellowship in Paediatric Oncology from prestigious Tata Memorial Centre, Mumbai. Before joining HCG, he was associated with B J Wadia Hospital for Children as Consultant in Paediatric Haematology and Oncology.
With over 12 years of experience in Paediatrics and Paediatric Haematology and Oncology, his areas of interest includes all kind of haematological cancers like ALL, AML, APML, CML, Lymphomas, LCH, HLH etc.) and solid tumors like Ewing's Sarcoma, Osteosarcoma, Rhabdomyosarcoma, Hepatoblastoma, Wilm’s Tumour, Neuroblastoma and Brain Tumors like Medulloblastoma, Ependymoma, Gliomas etc as well as Benign hematological disorders like Thalassemia, Sickle Cell Disease, Immune Thrombocytopenia, AIHA, etc.
Chemotherapy including High Dose Chemotherapy
Bone Marrow Aspiration and Biopsy
PICC line placement
Training and Certifications
He has completed his fellowship training in paediatric oncology from Tata Memorial Hospital, Mumbai.
He was awarded as Best paper presentation in Poster category in SIOP ASIA conference in March 2021 for his presentation on Effectiveness of oral metronomic chemotherapy as a bridge to high dose chemotherapy in AML presenting with fungal pneumonia AND /OR MDR BUG in rectal swab.
He is a member of various Professional bodies in India like IAP, PHO-IAP, AMC,NNF and others
He has been a DNB teacher for Post Graduate Students in Pediatrics and has been a DNB Thesis Guide
Pediatric Hospitalizations Associated with 2009 Pandemic Influenza A (H1N1): An Experience from a Tertiary Care Center in North India (Indian J Pediatr (2010) 77:981–985)
Effectiveness of oral metronomic chemotherapy as a bridge to high dose chemotherapy in AML presenting with fungal pneumonia AND /OR MDR BUG in rectal swab; October 2020; Pediatric Hematology Oncology Journal 5(4)DOI: 10.1016/j.phoj.2021.04.094
Teleconsultation in pediatric hematology-oncology practice – Dawning of a new era December 2021 Pediatric Hematology Oncology Journal 6(4):S65DOI: 10.1016/j.phoj.2022.03.170
Ghosal hematodiaphyseal dysplasia- Rare cause of refractory anemia;December 2021; Pediatric Hematology Oncology Journal 6(4):S41DOI: 10.1016/j.phoj.2022.03.103
Transcranial doppler screening in patients with sickle cell anemia in tertiary care hospital; December 2021;Pediatric Hematology Oncology Journal 6(4):S45-S46DOI: 10.1016/j.phoj.2022.03.114
Baseline nutrition in pediatric cancer therapy: A potential game changer December 2021 Pediatric Hematology Oncology Journal 6(4):S57DOI: 10.1016/j.phoj.2022.03.145
Blood stream infections in pediatric oncology patients in a tertiary care setup; December 2021;Pediatric Hematology Oncology Journal 6(4):S57DOI: 10.1016/j.phoj.2022.03.146
Clinico-hematological profile of pediatric acute megakaryoblastic leukemia - Single center experience; December 2021;Pediatric Hematology Oncology Journal 6(4):S30-S31DOI: 10.1016/j.phoj.2022.03.077
HCG - The Specialist in Cancer Care, India’s largest provider of cancer care, is at the forefront of the battle against cancer. Through its network of 24 comprehensive cancer centers, spread across India, HCG has brought advanced cancer care to the doorstep of millions of people.